BNR Burning Rock Biotech | €8.30 -1.8% | 3/15/2023 | | Set Price Target | €930.00 | | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 3/15/2023 |
BNR Burning Rock Biotech | €8.30 -1.8% | 3/8/2023 | | Set Price Target | €800.00 | | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 3/8/2023 |
BNR Burning Rock Biotech | €8.30 -1.8% | 11/28/2022 | | Set Price Target | €800.00 | | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 11/28/2022 |
BNR Burning Rock Biotech | €8.30 -1.8% | 11/9/2022 | | Set Price Target | €860.00 | | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 11/9/2022 |
BNR Burning Rock Biotech | €8.30 -1.8% | 8/12/2022 | | Set Price Target | €860.00 | | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 8/12/2022 |
BNR Burning Rock Biotech | €8.30 -1.8% | 6/14/2022 | | Set Price Target | €920.00 | | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 6/14/2022 |
ETR Entergy | $87.74 -0.5% | 5/16/2022 | | Set Price Target | $88.50 | | 00.00% | View details for Warburg Research rating of Entergy (NYSE:ETR) on 5/16/2022 |
BNR Burning Rock Biotech | €8.30 -1.8% | 5/11/2022 | | Set Price Target | €875.00 | | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 5/11/2022 |
BNR Burning Rock Biotech | €8.30 -1.8% | 3/15/2022 | | Set Price Target | €875.00 | | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 3/15/2022 |
BNR Burning Rock Biotech | €8.30 -1.8% | 2/9/2022 | | Set Price Target | €875.00 | | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 2/9/2022 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
BNR Burning Rock Biotech | €8.30 -1.8% | 11/9/2021 | | Set Price Target | €850.00 | | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 11/9/2021 |
BNR Burning Rock Biotech | €8.30 -1.8% | 9/15/2021 | | Set Price Target | €850.00 | | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 9/15/2021 |
BNR Burning Rock Biotech | €8.30 -1.8% | 8/12/2021 | | Set Price Target | €850.00 | | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 8/12/2021 |
BNR Burning Rock Biotech | €8.30 -1.8% | 7/23/2021 | | Set Price Target | €820.00 | | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 7/23/2021 |
BNR Burning Rock Biotech | €8.30 -1.8% | 6/18/2021 | | Set Price Target | €720.00 | Neutral | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 6/18/2021 |
BNR Burning Rock Biotech | €8.30 -1.8% | 3/10/2021 | | Set Price Target | €690.00 | Buy | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 3/10/2021 |
BNR Burning Rock Biotech | €8.30 -1.8% | 11/4/2020 | | Set Price Target | €580.00 | Buy | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 11/4/2020 |
BNR Burning Rock Biotech | €8.30 -1.8% | 9/16/2020 | | Set Price Target | €580.00 | Buy | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 9/16/2020 |
BNR Burning Rock Biotech | €8.30 -1.8% | 8/7/2020 | | Set Price Target | €580.00 | Buy | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 8/7/2020 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 8/6/2020 | | Set Price Target | €108.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 8/6/2020 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 7/29/2020 | | Set Price Target | €108.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 7/29/2020 |
BNR Burning Rock Biotech | €8.30 -1.8% | 7/23/2020 | | Set Price Target | €590.00 | Buy | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 7/23/2020 |
QGEN QIAGEN | $47.54 +1.1% | 6/23/2020 | | Reiterated Rating | | Hold ➝ Neutral | 00.00% | View details for Warburg Research rating of QIAGEN (NYSE:QGEN) on 6/23/2020 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 5/14/2020 | | Set Price Target | €106.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 5/14/2020 |
BNR Burning Rock Biotech | €8.30 -1.8% | 5/8/2020 | | Set Price Target | €450.00 | Neutral | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 5/8/2020 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 5/7/2020 | | Set Price Target | €106.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 5/7/2020 |
QGEN QIAGEN | $47.54 +1.1% | 5/6/2020 | | Reiterated Rating | | Hold | 00.00% | View details for Warburg Research rating of QIAGEN (NYSE:QGEN) on 5/6/2020 |
BNR Burning Rock Biotech | €8.30 -1.8% | 3/4/2020 | | Set Price Target | €500.00 | Neutral | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 3/4/2020 |
BNR Burning Rock Biotech | €8.30 -1.8% | 11/6/2019 | | Set Price Target | €500.00 | Buy | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 11/6/2019 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 7/30/2019 | | Set Price Target | €103.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 7/30/2019 |
BNR Burning Rock Biotech | €8.30 -1.8% | 7/18/2019 | | Set Price Target | €500.00 | Buy | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 7/18/2019 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 6/14/2019 | | Set Price Target | €103.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 6/14/2019 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 5/14/2019 | | Set Price Target | €103.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 5/14/2019 |
BNR Burning Rock Biotech | €8.30 -1.8% | 5/9/2019 | | Set Price Target | €550.00 | Buy | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 5/9/2019 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 4/9/2019 | | Set Price Target | €103.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 4/9/2019 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 4/2/2019 | | Set Price Target | €103.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 4/2/2019 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 3/27/2019 | | Set Price Target | €103.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 3/27/2019 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 3/20/2019 | | Set Price Target | €103.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 3/20/2019 |
BNR Burning Rock Biotech | €8.30 -1.8% | 3/8/2019 | | Set Price Target | €550.00 | Buy | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 3/8/2019 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 3/7/2019 | | Set Price Target | €103.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 3/7/2019 |
|
MRK Merck & Co., Inc. | €84.59 +0.6% | 2/28/2019 | | Set Price Target | €103.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 2/28/2019 |
DB Deutsche Bank Aktiengesellschaft | $35.23 -0.3% | 1/25/2019 | | Reiterated Rating | | Hold | 00.00% | View details for Warburg Research rating of Deutsche Bank Aktiengesellschaft (NYSE:DB) on 1/25/2019 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 11/14/2018 | | Set Price Target | €103.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 11/14/2018 |
BNR Burning Rock Biotech | €8.30 -1.8% | 11/12/2018 | | Set Price Target | €570.00 | Buy | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 11/12/2018 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 11/1/2018 | | Set Price Target | €103.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 11/1/2018 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 10/16/2018 | | Set Price Target | €100.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 10/16/2018 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 9/12/2018 | | Set Price Target | €100.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 9/12/2018 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 8/28/2018 | | Set Price Target | €100.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 8/28/2018 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 8/9/2018 | | Set Price Target | €100.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 8/9/2018 |
BNR Burning Rock Biotech | €8.30 -1.8% | 8/8/2018 | | Set Price Target | €600.00 | Buy | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 8/8/2018 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 7/31/2018 | | Set Price Target | €100.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 7/31/2018 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 7/3/2018 | | Set Price Target | €105.00 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 7/3/2018 |
BNR Burning Rock Biotech | €8.30 -1.8% | 3/16/2018 | | Set Price Target | €600.00 | Buy | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 3/16/2018 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 3/7/2018 | | Set Price Target | €115.00 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 3/7/2018 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 2/16/2018 | | Set Price Target | €115.00 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 2/16/2018 |
BNR Burning Rock Biotech | €8.30 -1.8% | 12/20/2017 | | Set Price Target | €630.00 | Buy | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 12/20/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 12/13/2017 | | Set Price Target | €115.00 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 12/13/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 11/29/2017 | | Set Price Target | €115.00 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 11/29/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 11/9/2017 | | Set Price Target | €115.00 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 11/9/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 10/2/2017 | | Set Price Target | €115.00 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 10/2/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 9/26/2017 | | Set Price Target | €115.00 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 9/26/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 9/6/2017 | | Set Price Target | €115.00 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 9/6/2017 |
BNR Burning Rock Biotech | €8.30 -1.8% | 8/14/2017 | | Set Price Target | €520.00 | Buy | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 8/14/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 8/3/2017 | | Set Price Target | €116.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 8/3/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 7/7/2017 | | Set Price Target | €116.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 7/7/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 6/20/2017 | | Set Price Target | €116.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 6/20/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 5/29/2017 | | Set Price Target | €116.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 5/29/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 5/22/2017 | | Set Price Target | €116.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 5/22/2017 |
BNR Burning Rock Biotech | €8.30 -1.8% | 5/20/2017 | | Set Price Target | €530.00 | Neutral | 00.00% | View details for Warburg Research rating of Burning Rock Biotech (NASDAQ:BNR) on 5/20/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 5/15/2017 | | Set Price Target | €116.00 | Neutral | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 5/15/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 4/26/2017 | | Set Price Target | €115.00 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 4/26/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 3/20/2017 | | Set Price Target | €114.00 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 3/20/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 3/9/2017 | | Set Price Target | €110.00 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 3/9/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 2/22/2017 | | Set Price Target | €110.00 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 2/22/2017 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 8/4/2016 | | Set Price Target | €103.10 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 8/4/2016 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 5/19/2016 | | Set Price Target | €103.10 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 5/19/2016 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 3/9/2016 | | Set Price Target | €103.10 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 3/9/2016 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 3/3/2016 | | Set Price Target | €103.10 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 3/3/2016 |
DTE DTE Energy | €136.44 +0.0% | 2/25/2016 | | Set Price Target | €18.50 | Buy | 00.00% | View details for Warburg Research rating of DTE Energy (NYSE:DTE) on 2/25/2016 |
DTE DTE Energy | €136.44 +0.0% | 2/17/2016 | | Set Price Target | €18.50 | Buy | 00.00% | View details for Warburg Research rating of DTE Energy (NYSE:DTE) on 2/17/2016 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 12/14/2015 | | Set Price Target | €103.10 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 12/14/2015 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 12/7/2015 | | Set Price Target | €103.10 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 12/7/2015 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 11/12/2015 | | Set Price Target | €103.10 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 11/12/2015 |
DTE DTE Energy | €136.44 +0.0% | 11/5/2015 | | Set Price Target | €18.50 | Buy | 00.00% | View details for Warburg Research rating of DTE Energy (NYSE:DTE) on 11/5/2015 |
DTE DTE Energy | €136.44 +0.0% | 10/29/2015 | | Set Price Target | €18.50 | Buy | 00.00% | View details for Warburg Research rating of DTE Energy (NYSE:DTE) on 10/29/2015 |
MRK Merck & Co., Inc. | €84.59 +0.6% | 9/25/2015 | | Set Price Target | €103.10 | Buy | 00.00% | View details for Warburg Research rating of Merck & Co., Inc. (NYSE:MRK) on 9/25/2015 |
DB Deutsche Bank Aktiengesellschaft | $35.23 -0.3% | 9/18/2015 | | Reiterated Rating | | Hold | 00.00% | View details for Warburg Research rating of Deutsche Bank Aktiengesellschaft (NYSE:DB) on 9/18/2015 |